• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Talkspace Announces First Quarter 2024 Results

    5/7/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email

    1Q 2024 Total revenue grew 36% year-over-year

    1Q 2024 Payor revenue grew 92% year-over-year

    Reduced GAAP Net loss to $1.5 million from $8.8 million year-over-year

    Delivers first profitable quarter with Adjusted EBITDA1 of $0.8 million

    NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Talkspace, Inc. (NASDAQ:TALK), today reported first quarter 2024 financial results.

      Three Months
       
    Three Months Ended March 31, 2024 (Unaudited) Results % Variance from Prior Year
    (In thousands unless otherwise noted)    
    Number of eligible lives at period end (in millions)  131.4  34%
    Number of completed Payor sessions  284.2  65%
    Number of Consumer active members at period end  11.1  (26)%
         
    Total revenue  $45,416  36%
    Gross profit  $21,731  30%
    Gross margin %  47.8%  
    Operating expenses  $23,410  (9)%
    Net loss  $(1,466)  83%
    Adjusted EBITDA1  $774  112%
    Cash and cash equivalents at period end  $120,278  —
           
    (1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most direct comparable GAAP measure, see "Reconciliation of Non-GAAP Results to GAAP Results."



    Dr. Jon Cohen, CEO of Talkspace, said, "We kicked off 2024 with strong momentum, building on our pivotal achievements from last year. Our first quarter results showcase a 36% year-over-year increase in revenue, driven by our deepening engagement and expanding reach within our Payor category. We also made exciting progress with our recent launches in New York City and the Baltimore County Public School system, two initial clients underpinning our efforts to combat the teen mental health crisis."

    "Importantly, this also marks our first quarter of profitability on an adjusted EBITDA basis. Our cash position, our streamlined operations, and our defined growth strategy give me confidence we are well-equipped to continue advancing our mission to deliver accessible and high-quality mental healthcare. As we continue to scale, our dedication to operational excellence is not only providing greater access to mental healthcare, but also enhancing the quality of care we provide for our members and the experience for our provider network," added Dr. Cohen.

    First Quarter 2024 Key Performance Metrics

    • Revenue increased 36% over the prior-year period to $45.4 million, driven by a 92% year-over-year increase in Payor revenue and a 14% year-over-year increase in Direct to Enterprise ("DTE") revenue; partially offset by a 29% year-over-year consumer revenue decline.
    • Gross profit increased 30% over the prior-year period to $21.7 million, and gross margin declined to 47.8% from 50.2% year-over-year, driven by a shift in revenue mix towards Payor.
    • Operating expenses were $23.4 million, down 9% year-over-year, driven primarily by efficiencies in Research & Development and Clinical Operations.
    • Net loss was $(1.5) million, an improvement from $(8.8) million net loss in the first quarter of 2023, primarily driven by an increase in revenues and a reduction in operating expenses.
    • Adjusted EBITDA was $0.8 million, an improvement from $(6.4) million in the first quarter of 2023, primarily driven by an increase in revenues and a reduction in operating expenses.



    Financial Guidance

    Full fiscal year 2024 guidance remains unchanged. Based on current market conditions and expectations and what the Company knows today, Talkspace expects revenue to be in the range of $185 million to $195 million, growth of 23-30%, and adjusted EBITDA to be in the range of $4 million to $8 million.

    Conference Call, Presentation Slides, and Webcast Details

    The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 330-2391 for U.S. participants, or +1 (240) 789-2702 for international participants, and referencing participant code 2348878. A replay will be available shortly after the call's completion and remain available for approximately 90 days.

    About Talkspace

    Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.

    Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace's core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.

    All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 131 million Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.

    For more information, visit www.talkspace.com.

    For Investors:

    ICR Westwicke

    [email protected]

    For Media:

    John Kim

    SKDK

    (310) 997-5963

    [email protected]

    Forward Looking Statements

    This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast", "future", "intend," "may," "might", "opportunity", "plan," "possible", "potential," "predict," "project," "should," "strategy", "strive", "target," "will," or "would", the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to factors and the other risks and uncertainties described under the caption "Risk Factors" in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 13, 2024, and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.

     
    Talkspace, Inc.

    Condensed Consolidated Statements of Operations

     
     Three Months Ended

    March 31,
      
     2024 2023 % Change
    (in thousands, except percentages, share and per share data)Unaudited Unaudited  
    Revenue:     
    Payor revenue$28,508 $14,811 92.5
    DTE revenue9,913 8,676 14.3
    Consumer revenue6,995 9,849 (29.0)
    Total revenue45,416 33,336 36.2
    Cost of revenues23,685 16,588 42.8
    Gross profit21,731 16,748 29.8
    Operating expenses:     
    Research and development3,739 5,353 (30.2)
    Clinical operations, net1,464 1,601 (8.6)
    Sales and marketing13,009 13,469 (3.4)
    General and administrative5,198 5,364 (3.1)
    Total operating expenses23,410 25,787 (9.2)
    Operating loss(1,679) (9,039) 81.4
    Financial (income), net(378) (424) (10.8)
    Loss before taxes on income(1,301) (8,615) 84.9
    Taxes on income165 143 15.4
    Net loss$(1,466) $(8,758) 83.3
    Net loss per share:     
    Basic and Diluted$(0.01) $(0.05) 80.0
    Weighted average number of common shares:     
    Basic and Diluted168,846,946 161,797,781  



     
    Talkspace, Inc.

    Condensed Consolidated Balance Sheets

       
     March 31, 2024  December 31, 2023 
    (in thousands)Unaudited    
    ASSETS     
    CURRENT ASSETS:     
    Cash and cash equivalents$120,278  $123,908 
    Accounts receivable 11,035   10,174 
    Other current assets 4,417   5,718 
    Total current assets 135,730   139,800 
    Other long-term assets 2,546   2,421 
    Total assets$138,276  $142,221 
    LIABILITIES AND STOCKHOLDERS' EQUITY     
    CURRENT LIABILITIES:     
    Accounts payable$5,805  $6,111 
    Deferred revenues 2,883   3,069 
    Accrued expenses and other current liabilities 6,998   12,468 
    Total current liabilities 15,686   21,648 
    Warrant liabilities 2,988   1,842 
    Other liabilities 24   85 
    Total liabilities 18,698   23,575 
    STOCKHOLDERS' EQUITY:     
    Common stock 16   16 
    Additional paid-in capital 391,412   389,014 
    Accumulated deficit (271,850)  (270,384)
    Total stockholders' equity 119,578   118,646 
    Total liabilities and stockholders' equity$138,276  $142,221 



     
    Talkspace, Inc.

    Condensed Consolidated Statements of Cash Flows

     
     Three Months Ended

    March 31,
     
     2024  2023 
    (in thousands)Unaudited  Unaudited 
    Cash flows from operating activities:     
    Net loss$(1,466) $(8,758)
    Adjustments to reconcile net loss to net cash used in operating activities:     
    Depreciation and amortization 201   306 
    Stock-based compensation 2,252   2,303 
    Remeasurement of warrant liabilities 1,146   189 
    Increase in accounts receivable (861)  (2,820)
    Decrease in other current assets 1,301   559 
    (Decrease) increase in accounts payable (306)  1,213 
    Decrease in deferred revenues (186)  (232)
    Decrease increase in accrued expenses and other current liabilities (5,470)  (6,702)
    Other (2)  (95)
    Net cash used in operating activities (3,391)  (14,037)
    Cash flows from investing activities:     
    Purchase of property and equipment (385)  (9)
    Proceeds from sale of property and equipment —   28 
    Net cash used in investing activities (385)  19 
    Cash flows from financing activities:     
    Proceeds from exercise of stock options 741   621 
    Payments for employee taxes withheld related to vested stock-based awards (595)  (65)
    Net cash provided by financing activities 146   556 
    Net decrease in cash and cash equivalents (3,630)  (13,462)
    Cash and cash equivalents at the beginning of the period 123,908   138,545 
    Cash and cash equivalents at the end of the period$120,278  $125,083 



    Non-GAAP Financial Measures

    In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

    Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results.

    A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

    Adjusted EBITDA

    We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, and (iv) stock-based compensation expense.

     
    Talkspace, Inc.

    Reconciliation of Non-GAAP Results to GAAP Results

     
     Three Months Ended

    March 31,
     
     2024  2023 
    (in thousands)Unaudited  Unaudited 
    Net loss$(1,466) $(8,758)
    Add:     
    Depreciation and amortization 201   306 
    Financial (income), net (1) (378)  (424)
    Taxes on income 165   143 
    Stock-based compensation 2,252   2,303 
    Adjusted EBITDA$774  $(6,430)



    (1)For the three months ended March 31, 2024, financial (income), net, primarily consisted of $1.6 million of interest income from our money market accounts partially offset by $1.1 million in losses resulting from the remeasurement of warrant liabilities. For the three months ended March 31, 2023, financial (income), net, primarily consisted of $0.6 million of interest income from our money market accounts partially offset by $0.2 million in losses resulting from the remeasurement of warrant liabilities
      


    Primary Logo

    Get the next $TALK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    12/2/2021$2.00Hold
    Jefferies
    11/16/2021$10.00 → $3.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technology Officer Margolin Gil exercised 3,516 shares at a strike of $0.88 and sold $11,392 worth of shares (3,516 units at $3.24) (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/5/25 9:30:47 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Director Braunstein Douglas L was granted 5,757 shares, increasing direct ownership by 0.29% to 2,019,645 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/3/25 9:30:06 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Director Shachar Erez was granted 4,112 shares, increasing direct ownership by 1% to 336,461 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      6/3/25 9:30:05 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/5/25 4:00:06 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/3/25 9:30:03 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      2/28/25 9:55:04 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/14/24 4:24:23 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/9/24 7:24:33 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

      SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

      10/5/23 6:41:35 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Talkspace Inc.

      SCHEDULE 13G/A - Talkspace, Inc. (0001803901) (Subject)

      5/15/25 5:31:31 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Talkspace Inc.

      10-Q - Talkspace, Inc. (0001803901) (Filer)

      5/9/25 8:38:38 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Talkspace, Inc. (0001803901) (Filer)

      5/6/25 8:15:44 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Financials

    Live finance-specific insights

    See more
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace to Report First Quarter 2025 Results and Host Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its first quarter 2025 results on Tuesday, May 6, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and referencing participant code 1021845. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About Talkspace

      4/16/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces Fourth Quarter and Full Year 2024 Results

      Full year 2024 total revenue grew 25% year-over-year to $187.6 millionFull year 2024 net income of $1.1 million and adjusted EBITDA1 of $7.0 million 4Q 2024 total revenue grew 15% year-over-year to $48.7 million4Q 2024 net income of $1.2 million and adjusted EBITDA1 of $2.7 million NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2024 financial results.     Three Months Ended December 31, 2024 Year Ended December 31, 2024     Unaudited Results % Variance from Prior Year Results % Variance from Prior Year(In thousands unless otherwise noted)        Number of eligible lives at ye

      2/20/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Talkspace to Participate in Upcoming Investor Conferences

      NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following upcoming investor conferences: The Truist Healthcare Disruptors & Digital Health Conference, being held in New York, including 1x1 meetings with investors on Tuesday, June 24, 2025, and a panel discussion on "Addressing the Mental Health Crisis" with Chief Executive Officer, Dr. Jon Cohen, on Wednesday, June 25, 2025 at 2:40pm ET.The Northland Growth Conference, being held virtually, including 1x1 meetings with investors on Wednesday, June 25, 2025. About Talkspace Talkspace (NASDAQ:TALK) is a le

      6/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Becomes First Behavioral Health Provider to Integrate with Amazon Pharmacy, Offering Psychiatry Services and a More Seamless Medication Management Experience

      Amazon Pharmacy now streamlines medication fulfillment for Talkspace members. Talkspace (NASDAQ:TALK), a leading online behavioral health company, today announced a new collaboration with Amazon Pharmacy to simplify the pharmacy experience for Talkspace members and streamline medication management and adherence support for providers. Mental health medication adherence remains a significant challenge in the U.S., with adherence rates ranging between 45% and 55% for many common conditions. Cost and access are two of the most persistent barriers. A study published in JAMA Psychiatry found that 21% of individuals with depression did not fill a prescribed medication in the past year due to c

      5/29/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Navigate Drives Continued Momentum in its Partner Ecosystem; Adds Talkspace, movr, and Springbuk

      WEST DES MOINES, Iowa, May 7, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced strategic partnerships with Talkspace (NASDAQ:TALK), movr, and Springbuk, adding significant strength to its partner ecosystem. These leading solutions address three of the most urgent and costly areas in workforce health: mental health, musculoskeletal (MSK) care, and population health intelligence. "Employers are no longer willing to take a trial-and-error approach to employee health benefits," stated Troy Vincent, Founder and CEO of Navigate Wellbeing Solutions. "Our wellbeing solution

      5/7/25 11:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on Talkspace with a new price target

      Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

      4/3/25 8:18:33 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

      KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

      12/9/24 8:34:29 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Mizuho initiated coverage on Talkspace with a new price target

      Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00

      12/4/24 7:49:48 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    See more
    • Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

      New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

      9/17/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

      Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

      8/28/24 9:06:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Appoints John Mooney as Chief Product Officer

      NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

      6/5/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care